奥曲肽治疗消化系内分泌肿瘤进展
atin(SMS 201-955) in the management of Zollinger-Ellison syndrome: evid
ence for Sustained efficacy. Pancreas，1988；3(2)：145
2 Vinik AL, Lloyd R, Cho K. The use of somatostatin analog in gastro
enteropancreatic tumors other than carcinoid. Metabolism，1990；39(9 su
ppl)：156
3 Mozell EJ, Katz MD, Baxter JN, et al. Long-term efficacy of octreo
tide in the treatment of Zollinger-Ellison Syndrome. Arch Surg，1992；1
27：1019
4 Fluckiger A. Long-term therapy of a metastasizing pancreatic vipom
a using the somatostatin derivative octreotide. Schwei Med Wochenschr，
1992；122：1221
5 Maton PN, Hanks JB, Jekins SA, et al. Use of gut peptide receptor
agonists and antagonists in gastrointestinal disease. Gastroentreol Cli
n North Am，1992；21：551
6 Kvols LK, Becher V, Steer ML. Treatment of the malignant carcinoid
Syndrome. NEJM，1986；315：663
7 Kvols LK. Therapeutic considerations for malignant carcinoid syndr
ome. Acta Oncol，1989；28(3)：433
8 Yinik A, Binder M, Choil TK, et al. Treatment of the carcinoid syn
drome with the somatostatin analogue. Dig Dis Sci，1989；34(1)：14
9 Joensum H, Burroughs AK. Dramatic response of a metastatic careimo
id tumor to a comibnation of interferon and octreotide. Acta Endocrinol
Copenh，1992；126：184
10 Glaser B, Rosler A, Halperin Y. Chronic treatment of a benign i
ns
ulinoma using the longacting somatostatin analogue SMS 201-955. Isr J M
ed Sci，1990；26(1)：16
11 Verschoor L, Uitterlinden P, Lamberts SW, et al. On the use of a
new somatostatin analogue in the treatment of hypoglycaemia in patients
with insulinoma. Chin Endocrinool，1986；25(5)：555
12 Vance ML. Long-term treatment of 18 acromegalic patients with the
somatostatin analog octreotide. Arch Intern Med，1991；151：1573
13 Eijeck CHJ. Somatostatin receptor-dependent growth inhibition of
liver metastases by octreotide. Br J Surg，1994；81(9)：1333
14 Maton PN, Kussin P. The use of the long-acting somatostatin analo
gue, octreotide acetate. in patients with
★读了本文的人也读了：